Which of the following drugs was most likely prescribed for the 12-year-old girl with extensive jaundice?
Rationale:
Lamotrigine was most likely prescribed for the 12-year-old girl with extensive jaundice. Lamotrigine is an anticonvulsant known to cause severe skin reactions and hepatotoxicity, often leading to jaundice. Its association with liver impairment aligns with the patient's symptoms, making it the most plausible drug linked to extensive jaundice among the options provided.
A: Gabapentin Gabapentin primarily treats neuropathic pain and seizures but rarely causes liver damage or jaundice, making it an unlikely cause of extensive jaundice in a pediatric patient.
C: Phenobarbital Phenobarbital can cause liver enzyme elevations but is less commonly linked to severe jaundice compared to lamotrigine, reducing its likelihood as the cause in this scenario.
D: Diazepam Diazepam’s metabolism minimally impacts liver function and seldom results in jaundice, especially extensive jaundice, making it an improbable culprit in this 12-year-old girl's condition.
A patient is admitted to the emergency room with orthostatic hypotension and evidence of marked GI bleeding. Which of the following most accurately describes the probable autonomic response to this bleeding?
Rationale:
The probable autonomic response to marked GI bleeding includes a rapid heart rate, dilated pupils, and damp skin. This reflects sympathetic nervous system activation triggered by hypovolemia, leading to increased heart rate to maintain perfusion, pupil dilation for heightened alertness, and damp skin due to increased sweat gland activity. These are classic signs of a fight-or-flight response.
A: Slow heart rate, dilated pupils, damp skin. Parasympathetic activation causing bradycardia contradicts the expected sympathetic response to hypovolemia, making this option incompatible with shock physiology.
C: Slow heart rate, dry skin, increased bowel sounds. Bradycardia and enhanced gastrointestinal activity oppose sympathetic stimulation, while dry skin conflicts with the expected diaphoresis during acute bleeding.
D: Rapid heart rate, constricted pupils, increased bowel sounds. Pupillary constriction and increased bowel motility are parasympathetic traits, inconsistent with sympathetic dominance during hypovolemic stress, despite tachycardia being appropriate.
Which of the following opioids would be contraindicated in the patient with acute myocardial infarction?
Rationale:
Morphine would be contraindicated in the patient with acute myocardial infarction. Morphine can cause vasodilation and hypotension, which may worsen hemodynamic instability in acute myocardial infarction. Additionally, it can mask symptoms, complicating clinical assessment. Its depressant effects on respiration and potential to induce bradycardia make it unsuitable for immediate use in this context, posing significant risks to the patient’s cardiac status.
A: Amitriptyline Amitriptyline is a tricyclic antidepressant, not an opioid, and does not directly affect myocardial infarction management. It lacks the acute cardiovascular effects that contraindicate opioid use in this scenario.
B: Acetaminophen Acetaminophen is an analgesic and antipyretic without opioid properties, with minimal cardiovascular impact, making it safe for pain management in myocardial infarction patients.
C: Haloperidol Haloperidol is an antipsychotic agent, unrelated to opioid analgesics and does not influence myocardial infarction treatment or contraindications involving opioids.
Which of the following drugs most likely caused the patient's syndrome?
Rationale:
Haloperidol most likely caused the patient's syndrome. Haloperidol, a typical antipsychotic, frequently induces extrapyramidal symptoms and neuroleptic malignant syndrome due to dopamine receptor blockade, explaining the patient's presentation. Its pharmacologic profile aligns with the syndrome’s characteristic features, differentiating it from other options that lack such direct dopaminergic antagonism or are less commonly associated with this severe adverse effect.
A: Imipramine This tricyclic antidepressant primarily affects serotonin and norepinephrine reuptake, lacking a strong association with neuroleptic malignant syndrome or similar extrapyramidal symptoms, making it an unlikely causative agent here.
B: Temazepam As a benzodiazepine, Temazepam mainly enhances GABAergic neurotransmission, which does not typically produce neuroleptic malignant syndrome or significant motor side effects observed in this patient’s syndrome.
D: Fluoxetine This selective serotonin reuptake inhibitor primarily influences serotonin levels without causing dopamine receptor blockade, so it rarely leads to neuroleptic malignant syndrome or the described extrapyramidal symptoms.
In male sex organs system is responsible for erection.
Rationale:
The parasympathetic system is responsible for erection in the male sex organs. This system promotes vasodilation of penile arteries through the release of nitric oxide, increasing blood flow into the corpora cavernosa, resulting in erection. It counteracts sympathetic-induced vasoconstriction, facilitating relaxation of smooth muscles and enabling the engorgement necessary for erection, distinguishing it from other autonomic functions.
A: Sympathetic The sympathetic system primarily facilitates ejaculation and detumescence, causing vasoconstriction and contraction of smooth muscles, which opposes the relaxation needed for erection. Its role is more related to climax and post-erection states rather than initiating erection itself.
C: Norepinephrine Norepinephrine is a neurotransmitter linked to sympathetic activity causing vasoconstriction, which inhibits erection by restricting blood flow. It does not promote the vasodilation or smooth muscle relaxation essential for penile erection.
D: None of the above This choice dismisses the involvement of any system, overlooking the critical parasympathetic role in erection. The physiological mechanism depends on parasympathetic stimulation, making this option factually inaccurate.
Low doses of adrenaline dilate the following vascular bed
Rationale:
Low doses of adrenaline dilate the skeletal muscle vascular bed.
Skeletal muscle vessels respond to low adrenaline doses through β2-adrenergic receptor activation, causing vasodilation. This increases blood flow to muscles during stress or exercise, optimizing oxygen delivery. Other vascular beds predominantly exhibit α-adrenergic receptor-mediated vasoconstriction at low adrenaline concentrations, preventing dilation outside skeletal muscles.
A: Cutaneous Vessels constrict due to α-adrenergic receptor activity at low adrenaline levels, reducing skin blood flow rather than dilating.
B: Mucosal Adrenaline induces vasoconstriction in mucosal vessels, minimizing blood flow there instead of causing dilation under low dose conditions.
C: Renal Renal vasculature mainly experiences constriction via α-adrenergic receptors with low adrenaline doses, decreasing renal blood flow rather than dilation.
Dobutamine differs from dopamine in that
Rationale:
Dobutamine does not activate peripheral dopaminergic receptors. Dobutamine primarily stimulates β1-adrenergic receptors, enhancing cardiac contractility and output without significant activation of peripheral dopaminergic receptors, unlike dopamine which acts on these receptors to cause vasodilation and increased renal perfusion. This fundamental receptor specificity distinguishes dobutamine’s hemodynamic effects from dopamine’s broader receptor profile.
B: It does not activate adrenergic β receptors. Dobutamine selectively stimulates β1-adrenergic receptors, making this option inaccurate because it indeed activates adrenergic β receptors, which mediate its positive inotropic effects on the heart.
C: It causes pronounced tachycardia. Dobutamine generally causes mild to moderate increases in heart rate, not pronounced tachycardia, as its β1 stimulation enhances contractility more than heart rate acceleration compared to other agents.
D: It has good blood-brain barrier penetrability. Dobutamine poorly crosses the blood-brain barrier, limiting central nervous system effects; thus, this option misrepresents its pharmacokinetic property regarding brain penetration.
Which of the following drugs would be relatively contraindicated for a patient diagnosed with generalized anxiety disorder?
Rationale:
Diazepam would be relatively contraindicated for a patient diagnosed with generalized anxiety disorder. Diazepam, a benzodiazepine, carries risks of dependence, tolerance, and withdrawal symptoms, making it less suitable for long-term management of generalized anxiety disorder compared to other options that have safer profiles and more sustainable efficacy in chronic anxiety treatment without the same risk of abuse or cognitive impairment.
A: Venlafaxine Venlafaxine, a serotonin-norepinephrine reuptake inhibitor, effectively treats generalized anxiety disorder by improving mood and anxiety symptoms without substantial risk of dependence or cognitive side effects associated with benzodiazepines. It is commonly prescribed for long-term management.
B: Buspirone Buspirone is an anxiolytic specifically indicated for generalized anxiety disorder, offering efficacy without sedation or addiction potential, making it a safer option compared to benzodiazepines for chronic anxiety cases.
C: Paroxetine Paroxetine, a selective serotonin reuptake inhibitor, is widely used for generalized anxiety disorder due to its anxiolytic properties and favorable long-term safety profile, unlike benzodiazepines which pose higher risks of abuse.
To reduce the muscarinic side effects of oral forms of cholinesterase inhibitors they should be administered
Rationale:
Oral cholinesterase inhibitors should be administered with food or milk to reduce muscarinic side effects. Taking these medications alongside food or milk helps buffer the gastrointestinal tract, minimizing irritation and adverse effects such as nausea and vomiting. This co-administration slows absorption, reducing peak plasma concentrations that exacerbate muscarinic symptoms, thereby improving patient tolerance and adherence to therapy.
A: On empty stomach This option increases drug absorption speed, raising peak levels that intensify muscarinic side effects. Lack of food buffering leads to greater gastrointestinal irritation and higher incidence of nausea and discomfort.
C: With milk Administering solely with milk provides some buffering, but lacks the comprehensive digestive benefits of a full meal. Milk alone may not sufficiently slow absorption to minimize muscarinic adverse effects effectively.
D: One hour after food Waiting an hour delays administration, allowing stomach emptying and reducing buffering capacity. This timing may not adequately protect the gastrointestinal lining, thus failing to decrease muscarinic side effects substantially.
We have a 48-year-old female patient with a history of myasthenia gravis. She has been treated with an oral acetyl cholinesterase inhibitor for several years, and has done well till now. She presents with muscle weakness and other signs and symptoms that could reflect either a cholinergic crisis (excess dosages of her maintenance drug) or a myasthenic crisis (insufficient treatment). We will use a rapidly acting parenteral acetyl cholinesterase inhibitor (AChE) to help make the differential diagnosis. Which of the following drugs would be most appropriate for this use?
Rationale:
Edrophonium is the most appropriate rapidly acting parenteral acetyl cholinesterase inhibitor for differentiating between cholinergic and myasthenic crises in this patient.
Edrophonium acts quickly with a short duration, making it ideal for diagnostic use in myasthenia gravis crises. Its rapid onset allows immediate assessment of muscle strength improvement or worsening, aiding distinction between under- and over-treatment. This property is crucial for timely, accurate clinical decisions in this acute setting.
B: Malathion is an organophosphate insecticide with irreversible acetylcholinesterase inhibition, unsuitable for rapid, reversible diagnostic testing in myasthenic crisis differentiation due to prolonged effects and toxicity risks.
C: Physostigmine crosses the blood-brain barrier and has a longer duration, making it less ideal for rapid diagnostic testing in myasthenic crisis, lacking the brief action needed for clear differentiation.
D: Pralidoxime reactivates acetylcholinesterase inhibited by organophosphates but is not an acetyl cholinesterase inhibitor and thus cannot be used to diagnose or treat myasthenic or cholinergic crises.
Characteristics of Vitamin D and its metabolites include which one of the following?
Rationale:
Calcitriol is the major derivative responsible for increasing intestinal absorption of phosphate. Calcitriol, the hormonally active form of Vitamin D, enhances absorption of both calcium and phosphate in the intestines, crucial for bone mineralization. This metabolite binds to Vitamin D receptors, promoting synthesis of transport proteins that facilitate phosphate uptake, thereby maintaining mineral balance and skeletal health.
A: Act to decrease serum levels of calcium contradicts Vitamin D’s role, as its metabolites primarily increase or maintain calcium levels by enhancing absorption and reducing excretion, supporting physiological calcium homeostasis.
B: Activation of their Vitamin D receptors increases cellular cAMP inaccurately describes the signaling mechanism; Vitamin D receptor activation mainly influences gene transcription without directly elevating intracellular cAMP concentrations.
D: Metabolites of Vitamin D increase renal excretion of calcium opposes their function; these metabolites typically decrease calcium excretion to preserve serum calcium levels, aiding in mineral retention rather than elimination.
Which of the following neural pathways most likely represent the main site of therapeutic action of the drug in the 8-year-old boy diagnosed with ADHD?
Rationale:
The mesolimbic pathway most likely represents the main site of therapeutic action of the drug in the 8-year-old boy diagnosed with ADHD. This pathway is primarily involved in reward processing and motivation, which are often dysregulated in ADHD; many ADHD medications target dopamine transmission here to improve attention and reduce impulsivity by modulating neural circuits linked to behavioral control.
A: Tuberoinfundibular This pathway regulates prolactin secretion from the pituitary gland and is unrelated to attentional or behavioral regulation, making it an unlikely target for ADHD therapeutic effects.
C: Corticostriatal This pathway involves motor and habit formation circuits, more associated with movement disorders than the attentional and reward deficits targeted in ADHD treatment.
D: Mesocortical This pathway modulates executive function and cognition but is less directly implicated in the reward-driven mechanisms primarily affected by ADHD medications than the mesolimbic pathway.
Which of the following adverse effects was most likely to occur in the patient receiving local injections of botulinum toxin for benign essential blepharospasm?
Rationale:
Eyelid ptosis was most likely to occur in the patient receiving local injections of botulinum toxin for benign essential blepharospasm. Botulinum toxin acts by blocking acetylcholine release at the neuromuscular junction, causing localized muscle weakness. When injected near the eyelid muscles, unintended diffusion can weaken the levator palpebrae superioris, resulting in eyelid drooping known as ptosis.
A: Retinal detachment involves separation of the retina and is unrelated to botulinum toxin’s local neuromuscular effects in eyelid muscles. It is not a typical adverse event following such injections.
B: Visual hallucinations arise from central nervous system disturbances rather than peripheral muscle paralysis caused by botulinum toxin. This symptom does not correlate with localized eyelid injections.
C: Visual loss implies impairment of the retina or optic nerve function, which is not a direct consequence of botulinum toxin injections targeting eyelid muscles. Visual acuity remains mostly unaffected.
Which of the following drugs was most likely administered to facilitate avoidance from ethanol dependence?
Rationale:
Naltrexone was most likely administered to facilitate avoidance from ethanol dependence. Naltrexone works by blocking opioid receptors, reducing alcohol’s rewarding effects, which helps decrease cravings and relapse risk in alcohol-dependent individuals. It is a well-established pharmacological treatment specifically targeting the neurobiological mechanisms involved in alcohol addiction, promoting abstinence and supporting recovery.
A: Diazepam Primarily serves as an anxiolytic and sedative, used for alcohol withdrawal symptoms but not directly for preventing dependence or avoiding alcohol consumption.
B: Clonidine Mainly addresses autonomic symptoms during withdrawal but lacks efficacy in reducing alcohol craving or promoting long-term abstinence from ethanol dependence.
C: Disulfiram Causes unpleasant reactions to alcohol intake but does not reduce craving or reward mechanisms, making it less effective for facilitating avoidance compared to Naltrexone.
Which of the following cholinesterase inhibitors is said to produce more severe muscarinic side effects
Rationale:
Neostigmine is said to produce more severe muscarinic side effects. Neostigmine’s potent inhibition of acetylcholinesterase leads to increased acetylcholine at muscarinic receptors, causing pronounced parasympathetic stimulation. Its pharmacologic profile, including duration and receptor affinity, results in more intense muscarinic symptoms compared to other cholinesterase inhibitors, making it notably harsher in side effect severity within this drug class.
A: Pyridostigmine produces fewer muscarinic side effects due to its milder cholinesterase inhibition and longer duration, resulting in less intense parasympathetic stimulation relative to neostigmine’s stronger receptor engagement and side effect profile.
C: Ambenonium’s muscarinic side effects are generally less severe because its reversible inhibition and tissue selectivity reduce overstimulation, differentiating it from neostigmine’s more aggressive muscarinic receptor activation and adverse effects.
D: All of the above implies equal severity, which is inaccurate; neostigmine uniquely causes more pronounced muscarinic effects, unlike pyridostigmine and ambenonium, whose side effect profiles are comparatively milder and less intense.
A patient with Alzheimer's disease is taking an acetyl cholinesterase inhibitor specifically approved for that indication, primarily because it is quite lipophilic and so enters the CNS well. Which of the following drugs is the patient most likely receiving?
Rationale:
Donepezil is the drug most likely prescribed because it is a lipophilic acetylcholinesterase inhibitor specifically approved for Alzheimer's disease that effectively crosses the blood-brain barrier to enhance central cholinergic activity. Its chemical properties allow it to penetrate the CNS, improving cognitive symptoms by increasing acetylcholine levels in the brain, unlike other less lipophilic agents.
B: Edrophonium acts rapidly but is hydrophilic and used mainly for diagnostic purposes in myasthenia gravis, lacking CNS penetration and FDA approval for Alzheimer's disease treatment.
C: Neostigmine is a charged molecule with poor CNS penetration, primarily used for peripheral neuromuscular blockade reversal, not suitable for Alzheimer's due to limited central nervous system effects.
D: Pyridostigmine is a quaternary ammonium compound that does not cross the blood-brain barrier efficiently and is mainly indicated for myasthenia gravis, not Alzheimer's disease therapy.
Which mm. are innervated by n. facialis:
Rationale:
The mm. of facial expression are innervated by the n. facialis. This nerve, also known as the facial nerve, primarily controls muscles responsible for facial movements, expressions, and some glandular functions. It does not innervate muscles involved in swallowing, tongue movement, or neck stabilization, which are supplied by different cranial or cervical nerves specialized for those regions.
A: mm. of the soft palate are primarily innervated by the vagus nerve, not the facial nerve, as they are involved in swallowing and speech, requiring different motor control pathways.
B: infrahyoid mm. receive innervation from the ansa cervicalis, part of the cervical plexus, unrelated to the facial nerve’s motor functions.
D: skeletal muscles of the tongue are controlled by the hypoglossal nerve, which is dedicated to tongue movements, distinct from the facial nerve’s domain.
Tyramine induces release of noradrenaline from adrenergic nerve endings
Rationale:
Tyramine induces the release of noradrenaline from adrenergic nerve endings by a nonexocytotic process.
This process involves tyramine entering nerve terminals via uptake mechanisms, displacing noradrenaline from storage vesicles into the cytoplasm, and then releasing it into the synaptic cleft without requiring vesicle fusion or calcium influx, distinguishing it from typical neurotransmitter release methods.
A: By depolarizing the axonal membrane does not apply since tyramine’s mechanism bypasses membrane potential changes and directly displaces neurotransmitters intracellularly.
B: By mobilizing Ca2+ is inaccurate because tyramine-induced release occurs independently of calcium influx, unlike classical exocytotic neurotransmitter release pathways.
D: Only in the presence of MAO inhibitors is misleading; tyramine releases noradrenaline regardless of MAO inhibitor presence, although MAO inhibitors can potentiate its effects.
Which of the following drugs most likely caused the patient's signs and symptoms?
Rationale:
Amphetamine most likely caused the patient's signs and symptoms. Amphetamines increase central nervous system activity, leading to heightened alertness, increased heart rate, and potential agitation. These stimulatory effects align with the clinical presentation, distinguishing them from other substances that produce different neurological or physiological profiles, making amphetamines the most plausible cause based on symptomatology and drug action.
A: Cocaine produces intense euphoria and vasoconstriction but typically leads to more transient symptoms and different cardiovascular effects, lacking the prolonged stimulant impact characteristic of the patient's presentation.
B: Marijuana mainly causes relaxation, altered perception, and mild tachycardia, which do not match the heightened sympathetic symptoms observed here.
C: LSD induces profound hallucinations and altered sensory experiences rather than stimulant-driven physiological symptoms seen in this case.
Which of the following is an orally active drug that blocks sodium channels and decreases action potential duration?
Rationale:
Mexiletine is an orally active drug that blocks sodium channels and decreases action potential duration. It is a class IB antiarrhythmic that selectively inhibits sodium channels, shortening repolarization and action potential duration, especially in ischemic or depolarized cardiac tissue. Its oral bioavailability makes it suitable for long-term management of ventricular arrhythmias by stabilizing cardiac membranes and reducing excitability.
A: Adenosine works by activating adenosine receptors, causing transient AV nodal block but does not block sodium channels or decrease action potential duration, thus unrelated to the question's mechanism.
B: Amiodarone blocks multiple channels including potassium and sodium but primarily prolongs action potential duration rather than decreasing it, so it does not fit the question’s specific criteria.
D: Esmolol is a beta-blocker that reduces heart rate and conduction velocity without sodium channel blockade or shortening action potential duration; it acts through beta-adrenergic receptor antagonism.
Beta blockers are contraindicated in patients with which condition?
Rationale:
Beta blockers are contraindicated in patients with asthma. Beta blockers can provoke bronchospasm by blocking beta-2 adrenergic receptors in the airways, worsening respiratory symptoms in asthma patients. This can lead to severe breathing difficulties or asthma exacerbations, making their use unsafe and inappropriate in individuals with reactive airway diseases such as asthma.
B: Diabetes mellitus Beta blockers may mask hypoglycemia symptoms in diabetes but do not contraindicate usage; careful monitoring is needed rather than complete avoidance.
C: Hypertension Beta blockers effectively lower blood pressure and are commonly prescribed for hypertension management, making this condition not a contraindication.
D: Rheumatoid arthritis Rheumatoid arthritis does not interfere with beta blocker pharmacodynamics or safety; therefore, beta blockers are not contraindicated in this autoimmune disorder.
The most efficacious inhibitor of catecholamine synthesis in the body is
Rationale:
α-methyl-p-tyrosine is the most efficacious inhibitor of catecholamine synthesis in the body. It competitively inhibits tyrosine hydroxylase, the rate-limiting enzyme converting tyrosine to L-DOPA, thereby effectively reducing the production of dopamine, norepinephrine, and epinephrine. This direct blockade at the initial step of catecholamine biosynthesis makes it highly potent in decreasing overall catecholamine levels.
B: α-methyldopa acts primarily as a false neurotransmitter and antihypertensive agent rather than directly inhibiting catecholamine synthesis. Its mechanism involves incorporation into catecholamine pathways but does not strongly inhibit tyrosine hydroxylase.
C: α-methyl-norepinephrine functions as a sympathomimetic agent, mimicking norepinephrine effects but lacks significant inhibitory action on catecholamine biosynthetic enzymes, thus not effectively reducing overall catecholamine production.
D: Pyrogallol acts as a nonspecific antioxidant and has minor effects on catecholamine metabolism but does not specifically or potently inhibit the synthesis of catecholamines at the enzymatic level.
Selective B2 agonists produce all of the following EXCEPT:
Rationale:
Selective B2 agonists do not stimulate uterine contraction.
Selective B2 agonists primarily target B2 adrenergic receptors, causing bronchodilation and vasodilation, which can lower blood pressure. They preferentially stimulate B2 over B1 receptors, minimizing cardiac effects. However, these agents relax uterine smooth muscle rather than contracting it, making stimulation of uterine contraction an effect not associated with selective B2 agonists.
A: Stimulate B2 > B1 This is accurate because selective B2 agonists have a higher affinity for B2 receptors compared to B1, ensuring targeted bronchodilation with reduced cardiac stimulation.
B: Bronchodilation Bronchodilation occurs due to B2 receptor activation causing relaxation of airway smooth muscle, a hallmark therapeutic effect of selective B2 agonists in respiratory conditions.
C: Decrease of blood pressure Selective B2 agonists cause vasodilation, lowering peripheral resistance, which can reduce blood pressure, aligning with their pharmacodynamic profile.
ß-blockers
Rationale:
ß-blockers relieve symptoms of thyrotoxicosis. They effectively manage symptoms like tachycardia and tremors by blocking beta-adrenergic receptors, without affecting thyroid hormone production directly. This symptomatic relief is crucial during the initial treatment phase or while waiting for other therapies, such as antithyroid drugs, to reduce hormone synthesis and normalize thyroid function levels safely.
B: Should not be used along with carbimazole wrongly suggests contraindication; however, ß-blockers are often combined with carbimazole to control symptoms while carbimazole reduces hormone production.
C: Reduce the synthesis of hormones in the gland inaccurately attributes hormone suppression to ß-blockers, which only alleviate symptoms without altering thyroid hormone synthesis.
D: Should not be given before thyroid surgery mistakenly implies ß-blockers are contraindicated preoperatively, but they are used to stabilize heart rate and reduce surgical risk beforehand.
This drug is effective in all forms of epilepsy in all age groups.
Rationale:
Carbamazepine is effective in all forms of epilepsy across all age groups. This drug stabilizes the inactive state of sodium channels, reducing neuronal excitability broadly. It is widely used for partial and generalized tonic-clonic seizures, demonstrating efficacy in children and adults. Its broad-spectrum activity and tolerability make it a versatile antiepileptic agent suitable for diverse epileptic conditions.
A: Acetazolamide primarily treats specific seizure types like catamenial epilepsy and is less effective across all epilepsy forms or ages, limiting its universal applicability.
C: Ethosuximide exclusively targets absence seizures by inhibiting T-type calcium channels, lacking broader efficacy in other seizure types or age groups.
D: Felbamate is reserved for refractory epilepsy due to safety concerns, restricting its use and effectiveness across all seizure types and ages.
The antibiotic that may accentuate the neuromuscular blockade produced by d-tubocurarine is
Rationale:
The antibiotic that may accentuate the neuromuscular blockade produced by d-tubocurarine is Streptomycin.
Streptomycin enhances neuromuscular blockade by interfering with acetylcholine release at the neuromuscular junction, potentiating the effect of d-tubocurarine. This potentiation increases muscle relaxation and paralysis, making streptomycin significant in clinical contexts where neuromuscular blocking agents are used, requiring careful dosage adjustment to avoid excessive blockade and associated complications.
A: Penicillin G Penicillin G primarily targets bacterial cell wall synthesis and does not influence neuromuscular transmission or interact significantly with d-tubocurarine’s mechanism at the neuromuscular junction.
B: Erythromycin Erythromycin mainly inhibits bacterial protein synthesis and lacks a direct effect on neuromuscular transmission, thus it does not potentiate the neuromuscular blockade caused by d-tubocurarine.
D: Chloramphenicol Chloramphenicol acts by inhibiting bacterial ribosomal protein synthesis and does not affect acetylcholine release or enhance neuromuscular blockade linked to d-tubocurarine.
A patient has been taking digoxin for several years for chronic heart failure is about to receive atropine for another condition. A common effect of digoxin (at therapeutic blood levels) that can be almost entirely blocked by atropine is
Rationale:
Digoxin commonly causes an increased PR interval on the ECG, which atropine can almost entirely block. Digoxin enhances vagal tone, slowing AV nodal conduction and prolonging the PR interval. Atropine, an anticholinergic, inhibits vagal effects on the heart, restoring normal conduction velocity and shortening the PR interval, counteracting digoxin's vagotonic influence at therapeutic levels.
A: Decreased appetite Digoxin’s effect on appetite involves central mechanisms unrelated to vagal tone, so atropine does not significantly alter this side effect. Appetite changes are not mediated by parasympathetic blockade.
B: Increased atrial contractility Digoxin increases contractility through Na+/K+ ATPase inhibition, independent of vagal tone; atropine does not block this positive inotropic action.
D: Headaches Headaches are not a typical digoxin effect nor mediated by vagal pathways, so atropine administration does not influence this symptom.
Propranolol can produce the following EXCEPT:
Rationale:
Propranolol does not stimulate beta adrenergic receptors.
Propranolol is a non-selective beta blocker that works by blocking beta adrenergic receptors, reducing heart rate and contractility, leading to decreased blood pressure. It does not activate or stimulate these receptors but instead inhibits their normal sympathetic nervous system effects, which is why option A is not a possible effect of propranolol.
B: Blockade of beta adrenergic receptors is the primary action of propranolol, preventing sympathetic stimulation and reducing heart rate and blood pressure effectively.
C: Depression of cardiac contractility occurs because propranolol blocks beta-1 receptors in the heart, decreasing the force of contraction and myocardial oxygen demand.
D: Decreased blood pressure results from reduced cardiac output and inhibition of renin release, both consequences of beta receptor blockade by propranolol.
A 16-year-old-girl is found to have paroxysmal attacks of rapid heart rate. The antiarrhythmic of choice in most cases of acute AV nodal tachycardia is
Rationale:
Adenosine is the antiarrhythmic of choice in most cases of acute AV nodal tachycardia. Adenosine acts rapidly to transiently block AV node conduction, effectively terminating reentrant supraventricular tachycardias. Its very short half-life allows quick restoration of normal rhythm with minimal side effects, making it ideal for acute management in young patients presenting with paroxysmal rapid heart rates.
B: Amiodarone is primarily used for ventricular arrhythmias and has a slower onset with numerous side effects, making it unsuitable for rapid termination of acute AV nodal tachycardia episodes.
C: Flecainide is a class IC antiarrhythmic more appropriate for atrial arrhythmias and not first-line for acute AV nodal tachycardia due to its proarrhythmic potential.
D: Propranolol is a beta-blocker that slows AV nodal conduction but acts more gradually and is less effective than adenosine for immediate termination of acute AV nodal tachycardia.
A visitor from another city comes to your office complaining of incessant cough. He has diabetes and hypertension and has recently started taking a different antihypertensive medication. The most likely cause of his cough is
Rationale:
Enalapril is the most likely cause of the visitor’s incessant cough.
Enalapril, an ACE inhibitor, commonly induces a persistent dry cough by increasing bradykinin levels in the respiratory tract. This side effect is well-documented, especially in patients recently started on the medication. The visitor’s recent antihypertensive change and symptoms strongly suggest enalapril as the culprit for the cough.
B: Losartan does not typically cause cough, as it belongs to the angiotensin receptor blocker class, which lacks the bradykinin accumulation responsible for ACE inhibitor-induced cough.
C: Minoxidil primarily causes fluid retention and hypertrichosis, not cough, making it an unlikely cause of persistent respiratory symptoms in this patient.
D: Propranolol, a beta-blocker, is associated with bronchospasm in asthmatics but not with chronic dry cough in hypertensive patients without respiratory disease.
The following terminal nerves originate from fasciculus posterior (plexus brachialis):
Rationale:
The terminal nerves originating from the fasciculus posterior of the brachial plexus are the n. axillaris and n. radialis. The fasciculus posterior gives rise to these two nerves, which innervate the posterior compartments of the arm and forearm, controlling extension movements and sensation in those regions, consistent with anatomical and clinical knowledge.
B: n. axillaris and n. medianus combines one posterior nerve with a predominantly anterior nerve; n. medianus arises from fasciculi lateral and medial, not posterior.
C: None of the answers is true contradicts established anatomy, as option A correctly identifies nerves from the fasciculus posterior.
D: n. axillaris and n. musculocutaneus pairs one posterior nerve with one lateral nerve; n. musculocutaneus originates from the lateral fasciculus, not posterior.